HANNAH HOLCOMB: Open Payments
NPI 1861956336 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 72 payments from 13 companies in 2025. Trend: 2023 $970 · 2024 $1,405 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $618 |
| Madrigal Pharmaceuticals | 4 | $223 |
| QOL Medical, LLC | 5 | $133 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Janssen Biotech, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 7 | $41 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Celltrion USA Inc. | 2 | $38 |
Products named: RINVOQ, REZDIFFRA, SKYRIZI, Sucraid, XIFAXAN, VIBERZI, ENTYVIO, TREMFYA.
Industry payments across AL — which companies pay providers there.
